The recent credit crisis and slowing economy have resulted in an increase in distressed mergers and acquisitions (M&A) transactions. In this timely program, Foley attorneys Steven H. Hilfinger, Daljit S. Doogal, and Geoffrey S. Goodman, along with Miller Buckfire & Co. Director Alexander Tracy, discuss the issues, opportunities, and challenges both sellers and buyers face in distressed M&A transactions. Topics included:
- Should a transaction be effectuated in or out of bankruptcy?
- If in bankruptcy, should the transaction be consummated under a plan or as a Section 363 sale?
- What are the threshold considerations facing various constituencies, including the buyer, seller, senior lenders, junior creditors, and other stakeholders?
- Given today’s credit climate, what alternatives are available for financing a distressed M&A transaction?
- What critical issues should be addressed in the purchase agreement?
For additional information about Foley’s M&A Briefing Series, please contact Jackie Polson at [email protected].
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.